Dr. Sumru Bilge-Johnson from Akron Children’s Hospital shared her knowledge of this topic with the SOC for MSY ECHO community on October 14th, 2021.
Tag: pharmacotherapy
Pharmacotherapy of Tobacco Use Disorder
In this lecture, Dr. Dugan discusses the history of tobacco use and reviews the medications that may be effective for smoking cessation. By the end of this lecture, you will be able to: 1) identify pharmacologic targets for treatment of tobacco use disorder, 2) list the adverse effects seen with pharmacologic treatment of tobacco use disorder, and 3) compare the efficacy data for agents used for treatment of tobacco use disorder.
Long-Acting Injectable Antipsychotic Medications: Recent Findings
Dr. Smith discusses the most up-to-date information on the use of long-acting injectables for the treatment of psychosis in May 2021. For more information about the Integrated Care @ NEOMED (IC@N) ECHO program, visit https://libraryguides.neomed.edu/ICAN…The information shared during this presentation solely represent the opinions and expertise of the presenter and are not those of Northeast Ohio Medical University unless expressly stated otherwise.
Optimal Pharmacotherapy for Schizoaffective Disorder
In this lecture, Dr. Dugan discusses medications that might be useful in treating schizoaffective disorder. By the end of this lecture, you will be able to: 1) describe the pharmacotherapeutic medications used for the treatment of schizoaffective disorder (SAD) and 2) compare the efficacy and safety data of different medications for the treatment of patients with SAD.
Hyperprolactinemia: The medications that can cause it and what can be done about it.
In this lecture, Dr. Dugan discusses medications that commonly cause hyperprolactinemia and presents options for management. By the end of this lecture, you will be able to: 1) list the causes of elevated prolactin levels, 2) identify symptoms associated with elevated prolactin levels, and 3) compare the impact medications commonly used for mental health conditions have on prolactin levels.
MAO Inhibitors. How Do These Antidepressants Work and How to Use Them Safely
In this lecture, Dr. Dugan explains how the MAO inhibitors work and the mechanisms behind the potential risks. She also discusses the therapeutic benefits of these medications and how to use them safely. By the end of this lecture, you will be able to: 1) describe the mechanism of action of the monoamine oxidase inhibitors (MAOIs), 2) identify relevant interactions of MAOIs with medications and foods, and 3) evaluate efficacy data of MAOIs in treatment of depression.
Drug Interactions with Psychiatric Medications
In this lecture, Dr. Dugan covers the basics of drug metabolism and highlights several important psychiatric drug-drug interactions that patients as well as prescribers should be aware of. By the end of this lecture, you will be able to: 1) compare pharmacodynamic and pharmacokinetic drug interactions and 2) identify relevant drug interactions with medications used in the treatment of mental illnesses.
Tricyclic Antidepressants: An Overview
In this lecture, Dr. Dugan discusses the tricyclic antidepressants including their mechanism of action, indications, dosing, monitoring, and common side effects. By the end of this lecture, you will be able to: 1) describe the pharmacology of the tricyclic antidepressants (TCA), 2) identify relevant pharmacokinetic differences between TCAs, and 3) evaluate the literature on TCAs for the treatment of depression.
Addressing Clozapine Associated Sedation
In this lecture, Dr. Dugan looks at the prevalence of clozapine-associated sedation, discusses pharmacological actions of clozapine that may contribute to sedation, and surveys some treatment strategies to reduce or eliminate this side effect. By the end of this lecture, you will be able to: 1) describe the prevalence of clozapine associated sedation, 2) identify pharmacologic actions that may contribute to sedation with clozapine, and 3) evaluate treatment strategies for addressing sedation with clozapine.
Metformin in Psychiatric Practice
In this lecture, Dr. Dugan briefly reviews the pharmacology of metformin and describes studies that look at the potential uses for metformin in psychiatric practice. By the end of this lecture, you will be able to: 1) describe the pharmacology of metformin, 2) identify potential uses of metformin in the mental health field, and 3) outline a monitoring plan for patients on metformin.
